
Dr. Chan said clinical practice guidelines ideally cover about 75% of patients with ADHD.

Dr. Chan said clinical practice guidelines ideally cover about 75% of patients with ADHD.

Dr. Buchholz discussed the idea of screening and intervening in patients with food insecurity, both in the clinical setting and in the community.

A retina care team highlighted positive patient feedback from their makeshift system; could it be a long-term solution?

A greater rate of intravitreal injection appointments were delayed last year, causing worse patient scores in BCVA and OTC.

New cohort analyses show endophthalmitis was not significantly reduced in treatment encounters where both physicians and patients were masked.

Dr. Bujoreanu explains how treatments like Cognitive Behavioral Therapy can have a positive impact on chronic pain in pediatric patients.

Dr. Maguiness speaks of new forms of tinea capitis not traditionally seen in the United States, as well as common practices shared between parents and clinicians for the management of several hair and nail disorders.

A significantly increased risk of hospitalization from pneumonia was observed due to haemophilus influenzae.

During this video interview, Dr. Bujoreanu expresses the importance of the multidisciplinary approach of the biopsychosocial model in chronic pain treatment.

Children are now screened for autism at 18 and 24 months.

Dr. Hawryluk noted that acne is estimated to affect 35%-95% of pediatric patients worldwide, though proper diagnosis and treatment of this dermatological condition is possible.

Dr. Owotomo and fellow investigators evaluated 1298 children from the Washington DC area and found that called for greater asthma care by pulmonologists and allergists alike.

Dr. Buchholz discusses who is most at-risk of food insecurity and comorbid factors that stem from lack of access to healthy food.

Findings from YOSEMITE and RHINE show a significant rate of patients on faricimab were able to extend their dosing to once every 16 weeks after a year of therapy.

Positive phase 1 and 2 findings support an ongoing efficacy assessment of the Ref-1 inhibitor for diabetic retinopathy and diabetic macular edema.

A new cross-sectional analysis from ASRS 2021 show White patients are generally overrepresented in randomized, controlled trials for DME.

Josh Mali, MD, of The Eyes Associates, joins HCPLive to review the key news and developments coming out of the American Society of Retina Specialists 2021 Scientific Meeting.

A cohort assessment of the IRIS registry database shows about 1 in 10 patients to receive anti-VEGF and/or panretinal photocoagulation discontinue therapy for at least 1 year.

Fever is present in both KD and MIS-C, but there is lower prevalence of the 5 KD defining clinical features in MIS-C.

Telemedicine will likely continue to be used as a tool in autism management.

In this video interview, Dr. Lee-Kim explains the importance of understanding the results of a Complete Blood Count before rushing to refer a patient to a hematologist.

Dr. Hawryluk speaks of improving upon tolerability of existing therapies for atopic disease as well as promising new therapies on the horizon.

Dr. Erickson discussed screening for children prone to sudden cardiac arrest and sudden cardiac death based on an updated AAP policy statement.

Immigrant children were less likely to be diagnosed with ADHD compared to children of US born parents.

Cohen believes the emergency injection is not only cost-effective but the ideal treatment method for protecting vulnerable pediatric groups with allergies.

The AAP guidelines for ADHD were first released in 2000 and last updated in 2019.

Cohen details some of the diagnostic criteria for anaphylaxis in pediatric populations, differences in symptoms among children and adolescents, and the virtues of epinephrine.

Dr. Michalsky observed challenges in pediatric bariatric surgery, specifically growing consensus on its use, the use of BMI, and access to treatment.

Dr. Michalsky discusses the utility of bariatric surgical options in patients with a high body mass index.

Dr. De Keyser highlights the success of biologics such as omalizumab and dupilumab in the treatment of asthma and atopic dermatitis in pediatric populations.